January 12,2016
Riga, Latvia
Janis Romanovskis to become a Board Member of JSC
„Grindeks”
JSC „Grindeks”
today announces that starting from January 12, 2016 in accordance with
the decision of the Supervisory Council of JSC „Grindeks” Janis
Romanovskis who is also the Chief Finance and Administrative
Officer of JSC „Grindeks” has been elected as the Member of the
Board of JSC „Grindeks”.
Janis Romanovskis had also previously worked at „Grindeks” as the
Chairman of the Board and Chief Finance and Administrative
Officer. During his career Romanovskis has been the Chairman of the
Board of pharmaceutical companies „Recipe plus” and „Sentor Farm
aptiekas”, as well as the Finance Director of the IT company
„Komerccentrs DATI Grupa” and the Head of the Financial Management
Unit of JSC „Dati”.
Born in 1960, Janis Romanovskis graduated from Riga Secondary
School No. 1, Faculty of Economics of University of Latvia and Riga
International School of Economics and Business
Administration.
Janis Romanovskis does not own shares of JSC „Grindeks”.
The Chairman of the Board of JSC „Grindeks” Juris Bundulis and
Member of the Board, Commercial Director Ibraim Muhtsi will
continue their work at the Board of JSC
„Grindeks”.
About “Grindeks”
“Grindeks” is an international, vertically integrated
pharmaceutical company. Main fields of action are research,
development, manufacturing and sales of original products, generics
and active pharmaceutical ingredients. The Group of “Grindeks”
consists of five subsidiary companies in Latvia, Estonia, Russia
and Slovakia as well as representative offices in 13
countries.
“Grindeks” specializes in the heart and cardiovascular, CNS and
anti-cancer medication therapeutic groups. A range of products
covers a successful combination of original products and generics,
with the original products Mildronate® and Ftorafur® and more than
100 forms of generics included therein. Currently “Grindeks”
produces 25 active pharmaceutical
ingredients.
Products of the company are exported to 60 countries and its export
comprises 94% of the total turnover. The main markets are: Russia
and other CIS countries, the Baltic States, the Netherlands,
Germany, Canada, the U.S., France, Ireland and
Japan.
To increase production capacity and develop infrastructure, since
2002 the company has accomplished many significant investment
projects, investing more than 70 million euros over the
years.
Further
information:
Laila Klavina
Head of the Communications Department, JSC “Grindeks”
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
laila.klavina@grindeks.lv
|